Global Perfluorocarbon-based Ultrasound Contrast Agents Market Growth 2024-2030

Global Perfluorocarbon-based Ultrasound Contrast Agents Market Growth 2024-2030

Perfluorocarbon-based ultrasound contrast agents are special types of ultrasound contrast agents. These contrast agents use perfluorocarbons as the gas filler within the microbubbles, and due to their good stability and biocompatibility, they have been widely used in medical imaging fields.

The global Perfluorocarbon-based Ultrasound Contrast Agents market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Perfluorocarbon-based Ultrasound Contrast Agents Industry Forecast” looks at past sales and reviews total world Perfluorocarbon-based Ultrasound Contrast Agents sales in 2023, providing a comprehensive analysis by region and market sector of projected Perfluorocarbon-based Ultrasound Contrast Agents sales for 2024 through 2030. With Perfluorocarbon-based Ultrasound Contrast Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Perfluorocarbon-based Ultrasound Contrast Agents industry.

This Insight Report provides a comprehensive analysis of the global Perfluorocarbon-based Ultrasound Contrast Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Perfluorocarbon-based Ultrasound Contrast Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Perfluorocarbon-based Ultrasound Contrast Agents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Perfluorocarbon-based Ultrasound Contrast Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Perfluorocarbon-based Ultrasound Contrast Agents.

United States market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Perfluorocarbon-based Ultrasound Contrast Agents is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Perfluorocarbon-based Ultrasound Contrast Agents players cover Bracco, GE Healthcare, Lantheus Medical Imaging, ImaRx Therapeutics, Microvascular Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Perfluorocarbon-based Ultrasound Contrast Agents market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Sulfur Hexafluoride
Perfluoropropane
Perfluorobutane
Others

Segmentation by Application:
Liver Ultrasonography
Angiographic Ultrasonography
Cardiac Ultrasonography
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bracco
GE Healthcare
Lantheus Medical Imaging
ImaRx Therapeutics
Microvascular Therapeutics
Qi-hui Biopharmaceutical
Feiruida Medical
SUNΛ Med-Engineering
Lizhuo Pharmaceutical
Fuman Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Perfluorocarbon-based Ultrasound Contrast Agents market?

What factors are driving Perfluorocarbon-based Ultrasound Contrast Agents market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Perfluorocarbon-based Ultrasound Contrast Agents market opportunities vary by end market size?

How does Perfluorocarbon-based Ultrasound Contrast Agents break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.